Dr Trish Holch, Senior Lecturer

Dr Trish Holch

Senior Lecturer

Prior to joining Leeds Beckett in 2016, Trish worked as a Research Fellow in the Patient Reported Outcomes Group at the University of Leeds, and she continues as an Honorary Research Fellow there. Trish was awarded her PhD in Psychology from the University of Leeds in 2009, and a BSc (Hons) Psychology degree from the same institution in 2003.

Trish is the co-lead of the Centre for Psychological Research (PsyCen) Health & Clinical Psychology group at Leeds Beckett devoted to achieving the objectives and meeting the research needs specific to the REF2021

Trish is an executive committee member of the British Psychosocial Oncology Society (BPOS) and a member of the International Psycho-Oncology Society (IPOS), the ISOQOL (International Society for Quality of Life Research) and their Best Practices for PROs- Reporting Taskforce (Patient Reported Outcomes).

Trish regularly sits on the scientific committees of ISOQOL, BPOS and the National PROMs Research Conference and peer reviews manuscripts for Psycho-Oncology and the International Journal of Radiation Oncology Biology Physics.

In 2017 Trish co-edited a special section on digital technologies in the Journal of Cancer Survivorship Research and Practice and the accompanying editorial, Introduction to special section on digital technology and cancer survivorship’

Current Teaching

Trish is a Senior Fellow of the Higher Education Academy and leader for the BSc (Hons) Final Year Project module and the quantitative strand of the Advanced Research Methods and Applied Health Psychology in Medical Practice modules. She also lectures on the Health Psychology and Behavioural Neuroscience modules on the BSc (Hons) Psychology course.

Research Interests

Trish undertakes both qualitative and quantitative applied health research including validation of measures, cognitive interviewing and delphi consensus methodologies. Trish’s interests include understanding health behaviours, factors influencing self-management of symptoms, electronic symptom monitoring, PROMs and electronic health literacy.

Trish has presented her research at over 30 national and international conferences including the International Society for Quality of Life Research (Budapest), the International Psycho-Oncology Society Congress (Dublin), European Society for Radiotherapy and Oncology (ESTRO) (Barcelona, Vienna), National PROMs conference and the British Psychosocial Oncology Society. Trish has authored over 15 research papers in peer-reviewed journals including Annals of Oncology, International Journal of Radiation Oncology Biology Physics, British Medical Journal (Supportive and Palliative Care) and Acta Oncologica.

In 2017 Trish was invited to deliver a pre-meeting clinical course at the International ESTRO conference in Vienna alongside Professor Cai Grau from Aarhus University Hospital Denmark. The course was entitled ‘Current and potential future roles of Patient Reported Outcome Measures (PROMs) in radiotherapy’ and brought together a distinguished faculty of PROM researchers and clinicians from within and outside the radiotherapy community.

Grants

  • A co-applicant on the Yorkshire Cancer Research Funded LiLAC (life after lung cancer project) which uses PROMs to enable comparison of two types of treatment for early stage lung cancer (£200,000)
  • A co-applicant on the College of Radiographers funded AIRPoRT (Assessment of Information Required by Patients Or relatives who have undergone radical lung Radiotherapy Treatment) (£10,000)    
  • A co-applicant on a Teenage Cancer Trust funded project developing a new model of emotional distress detection and management in teenagers and young adults (TYA) with cancer (£60,000).

Collaborations

  • University of Michigan, USA (orthopaedic department) to develop reporting guidelines for psychometric investigations of a Patient Reported Outcome Measure (PROM).
  • University of Manchester and the Teenage Cancer trust to validate a Young Persons Cancer Awareness Measure (YPCAM).
  • University of Leeds Patient Reported Outcomes Group on the National Institute of Health Research funded eRAPID (Electronic patient self-Reporting of Adverse-events: Patient Information and aDvice) Radiotherapy project.
  • Radiotherapy department at St James’s Institute of Oncology (Leeds) to improve service delivery by developing innovative models of follow-up.
  • Leeds Beckett University Diabetes Special Interest Research Group.

Supervision

Trish supervises Sue Iveson's PhD (NIHR Clinical Doctoral fellow) with Professor Georgina Jones:

An evaluation of a new online patient reported outcome measure (PROM) within a rare cancer in the United Kingdom (UK): establishing a national validated PROM within the UK Gestational Trophoblastic Disease (GTD) Service to improve patient care and support a new era of virtual clinics for GTD patients’

Trish Supervises Dr Paul Andrzejowski's Medical Doctorate (University of Leeds) with Professor Peter Giannoudis  'Functional outcomes in trauma (FIT)'

Dr Trish Holch, Senior Lecturer

Selected Outputs

  • Holch P; Holmes M; Rodgers Z; Dickinson S; Davidson S; Routledge J; Glennon J; Henry A; Franks K; Velikova G (2017) The acceptability and feasibility of eRAPID (electronic patient self-reporting of adverse-events: patient information and advice) in pelvic radiotherapy for cancer: views of patients relatives and staff.

    https://doi.org/10.1002/pon.4374

  • Holch P; Henry A; Davidson S; Gilbert A; Routledge J; Shearsmith L; Franks K; Ingleson E; Allbut A; Velikova G (2016) Acute and late adverse events associated with radical prostate cancer treatment : A systematic review of clinician and patient toxicity reporting in randomised controlled trials (RCT). In: 2016 World Congress of Psycho‐oncology, 17 October 2016 - 21 October 2016, Dublin, Ireland.

    https://doi.org/10.1002/pon.4272

  • Holch P; Warrington L; Ziegler L; Hector C; Keding A; Bamforth L; Harley C; Mitchell SA; Basch E; Velikova G (2012) Asking the right questions to get the right answers: using cognitive interviews to review the acceptability, comprehension and clinical meaningfulness of patient self-report adverse event items in oncology patients.

    https://doi.org/10.1007/s11136-012-0248-x

  • Absolom K; Warrington L; Hudson E; Hewison J; Morris C; Holch P; Carter R; Gibson A; Holmes M; Clayton B (2021) Phase III Randomized Controlled Trial of eRAPID: eHealth Intervention During Chemotherapy. Journal of Clinical Oncology, 39 (7), pp. 734-747.

    https://doi.org/10.1200/jco.20.02015

  • Pompili C; Holch P; Rogers Z; Absolom K; Clayton B; Franks K; Bekker H; Velikova G (2020) Patients’ confidence in treatment decisions for early stage non-small cell lung cancer (NSCLC). Health and Quality of Life Outcomes, 18

    https://doi.org/10.1186/s12955-020-01496-9

    View Repository Record

  • Holch P; Marwood JR (2020) EHealth Literacy in UK Teenagers and Young Adults: Exploration of Predictors and Factor Structure of the eHealth Literacy Scale (eHEALS). JMIR Formative Research, 4 (9),

    https://doi.org/10.2196/14450

    View Repository Record

  • Pompili C; Boele F; Absolom K; Holch P; Clayton B; Smyllie E; Franks K; Velikova G (2020) Patients’ views of routine quality of life assessment following a diagnosis of early-stage non-small cell lung cancer. Interactive Cardiovascular and Thoracic Surgery, 31 (3), pp. 324-330.

    https://doi.org/10.1093/icvts/ivaa123

    View Repository Record

  • Archer S; Holch P; Armes J; Calman L; Foster C; Gelcich S; MacLennan SJ; Absolom K (2020) “No turning back” Psycho‐oncology in the time of COVID‐19: Insights from a survey of UK professionals. Psycho-Oncology

    https://doi.org/10.1002/pon.5486

    View Repository Record

  • Absolom K; Warrington L; Holch P; Gibson A; Clayton B; Velikova G (2019) Online tool for monitoring adverse events in patients with cancer during treatment (eRAPID): field testing in a clinical setting. BMJ Open

    https://doi.org/10.1136/bmjopen-2018-025185

    View Repository Record

  • Holch P; Pini S; Henry AM; Davidson S; Routledge J; Brown J; Absolom K; Gilbert A; Franks K; Hulme C (2018) eRAPID electronic patient self-Reporting of Adverse-events: Patient Information and aDvice: a pilot study protocol in pelvic radiotherapy. Pilot Feasibility Stud, 4 (110), pp. 110-110.

    https://doi.org/10.1186/s40814-018-0304-6

    View Repository Record

  • Chauhan M; Holch P; Holbourn C (2018) Assessing the information and support needs of radical prostate cancer patients and acceptability of a group based treatment review: A questionnaire and qualitative interview study. Journal of Radiotherapy in Practice

    https://doi.org/10.1017/S1460396917000644

    View Repository Record

  • Absolom K; Holch P; Amir Z (2017) Introduction to special section on digital technology and cancer survivorship. Journal of cancer survivorship : research and practice

    https://doi.org/10.1007/s11764-017-0644-x

  • Holch P; Warrington L; Bamforth LCA; Keding A; Ziegler LE; Absolom K; Hector C; Harley C; Johnson O; Hall G (2017) Development of an integrated electronic platform for patient self-report and management of adverse events during cancer treatment. Annals of Oncology, 28 (9), pp. 2305-2311.

    https://doi.org/10.1093/annonc/mdx317

    View Repository Record

  • Pompili C; Franks KN; Brunelli A; Hussain YS; Holch P; Callister ME; Robson JM; Papagiannopoulos K; Velikova G (2017) Patient reported outcomes following video assisted thoracoscopic (VATS) resection or stereotactic ablative body radiotherapy (SABR) for treatment of non-small cell lung cancer: protocol for an observational pilot study (LiLAC). Journal of thoracic disease, 9 (8), pp. 2703-2713.

    https://doi.org/10.21037/jtd.2017.07.35

    View Repository Record

  • Absolom K; Holch P; Warrington L; Samy F; Hulme C; Hewison J; Morris C; Bamforth L; Conner M; Brown J (2017) Electronic patient self-Reporting of adverse-events: Patient information and advice (eRAPID): A randomised controlled trial in systemic cancer treatment. BMC Cancer, 17 (318),

    https://doi.org/10.1186/s12885-017-3303-8

    View Repository Record

  • Holch P; Henry AM; Davidson S; Gilbert A; Routledge J; Shearsmith L; Franks K; Ingleson E; Albutt A; Velikova G (2017) Acute and Late Adverse Events Associated With Radical Radiation Therapy Prostate Cancer Treatment : A Systematic Review of Clinician and Patient Toxicity Reporting in Randomized Controlled Trials. International Journal of Radiation Oncology Biology Physics, 97 (3), pp. 495-510.

    https://doi.org/10.1016/j.ijrobp.2016.11.008

  • Mercieca-Bebber R; Rouette J; Calvert M; King MT; McLeod L; Holch P; Palmer MJ; Brundage M (2017) Preliminary evidence on the uptake, use and benefits of the CONSORT-PRO extension. Quality of Life Research, pp. 1-11.

    https://doi.org/10.1007/s11136-017-1508-6

    View Repository Record

  • Warrington L; Holch P; Kenyon L; Hector C; Kozlowska K; Kenny AM; Ziegler L; Velikova G (2016) An audit of acute oncology services: patient experiences of admission procedures and staff utilisation of a new telephone triage system. Supportive Care in Cancer, 24 (12), pp. 5041-5048.

    https://doi.org/10.1007/s00520-016-3370-4

    View Repository Record

  • Holch P; Warrington L; Potrata B; Ziegler L; Hector C; Keding A; Harley C; Absolom K; Morris C; Bamforth L (2016) Asking the right questions to get the right answers: Using cognitive interviews to review the acceptability, comprehension and clinical meaningfulness of patient self-report adverse event items in oncology patients. Acta Oncologica

    https://doi.org/10.1080/0284186X.2016.1213878

    View Repository Record

  • Absolom K; Holch P; Woroncow B; Wright EP; Velikova G (2015) Beyond lip service and box ticking: how effective patient engagement is integral to the development and delivery of patient-reported outcomes. Quality of Life Research, 24 (5), pp. 1077-1085.

    https://doi.org/10.1007/s11136-014-0909-z

  • Gilbert A; Francischetto EO; Blazeby J; Holch P; Davidson S; Sebag-Montefiore D; Velikova G (2015) Choice of a patient-reported outcome measure for patients with anal cancer for use in cancer clinical trials and routine clinical practice: a mixed methods approach. Lancet, 385 Suppl 1 pp. S38-S38.

    https://doi.org/10.1016/S0140-6736(15)60353-1

  • Absolom K; Takeuchi E; Warrington L; Holch P; Hector C; Ingleson E; Kenyon L; Velikova G (2014) Using a patient-reported outcome measure in chemotherapy review consultations: The impact of an interactive doctor training session. QUALITY OF LIFE RESEARCH, 23 pp. 27-27.

    http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000352699800071&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=378ec14fd3cd2d2d756f42f58f326e84

  • Holch P; Absolom KL; Pini S; Hill KM; Lui A; Sharpe M; Richardson A; Hosker C; Velikova G (2011) Oncology professionals’ views on the use of antidepressants in cancer patients: a qualitative interview study. British Medical Journal Supportive and Palliative care, 1 pp. 301-305.

    doi:10.1136/bmjspcare-2011-000076

  • Absolom K; Holch P; Pini S; Hill K; Liu A; Sharpe M; Richardson A; Velikova G (2011) The detection and management of emotional distress in cancer patients: the views of health-care professionals. Psycho-Oncology, 20 (6), pp. 601-608.

    https://doi.org/10.1002/pon.1916

  • Rodgers RJ; Holch P; Tallett AJ (2010) Behavioural satiety sequence (BSS): Separating wheat from chaff in the behavioural pharmacology of appetite. Pharmacology Biochemistry and Behavior, 97 (1), pp. 3-14.

    https://doi.org/10.1016/j.pbb.2010.03.001

  • Boggiano MM; Chandler PC; Oswald KD; Rodgers RJ; Blundell JE; Ishii Y; Beattie AH; Holch P; Allison DB; Schindler M (2005) PYY3-36 as an anti-obesity drug target. Obesity Reviews, 6 (4), pp. 307-322.

    https://doi.org/10.1111/j.1467-789x.2005.00218.x

  • Cockell CS; Stokes MD (2004) Widespread colonization by polar hypoliths. Nature, 431 (7007), pp. 414-414.

    https://doi.org/10.1038/431414a

  • Madill A; Holch P (2004) A range of memory possibilities: the challenge of the false memory debate for clinicians and researchers. Clinical Psychology & Psychotherapy, 11 (5), pp. 299-310.

    https://doi.org/10.1002/cpp.378

  • Tschöp M; Castañeda TR; Joost HG; Thöne-Reineke C; Ortmann S; Klaus S; Hagan MM; Chandler PC; Oswald KD; Benoit SC (2004) Does gut hormone PYY3–36 decrease food intake in rodents?. Nature, 430 (6996), pp. 1-3.

    https://doi.org/10.1038/nature02665